|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Changes in inventories and raw materials and consumables used | |||||
| Employee benefits | |||||
| Other operating expenses | |||||
| Amortization and depreciation | |||||
| Impairment of assets | |||||
| Net other income | |||||
| Operating Profit / (Loss) | |||||
| Financial income | |||||
| Financial expenses | |||||
| Change in fair value of derivative warrant liabilities | |||||
| Foreign exchange gains/(losses) | |||||
| Financial Results | |||||
| Share of loss of equity-accounted investees | |||||
| Loss before Tax | |||||
| Income tax credit | |||||
| Loss for the Year | |||||
| Other comprehensive (loss)/income that may be reclassified to profit or loss in subsequent periods | |||||
| Currency translation differences in foreign operations, net of tax | |||||
| Changes in the fair value of debt instruments at fair value through other comprehensive income, net of tax | |||||
| Net other comprehensive (loss)/income that may be reclassified to profit or loss in subsequent periods | |||||
| Total other comprehensive income | |||||
| Total comprehensive loss for the year | |||||
| Equity holders of the Company | |||||
| Non-controlling interest | |||||
| Earnings per share | |||||
| Basic losses per share (euros per share) | |||||
| Diluted losses per share (euros per share) | |||||
Loading...
